begun and was continued until July 12, 1978, when all evidence of pul monary embolus had subsided. Examination of brushings from a brochoscopic examination showed malignant cells. The heparin therapy was discontinued and the patient was prepared for thoracotomy, but on July 30 bilateral thrombophlebitis of the lower extremities required that heparmntherapy be reinstituted. Despite adequate heparin treatment, re current pulmonary embolus was diagnosed. The patient underwent liga tion of the inferior vena cava on September 11, 1978. On September 15, a thoracotomy and left lower lobectomy were done and a large-cell poorly differentiated carcinoma with involvement of multiple nodes was diagnosed.
On September 18 , the patient was begun on coumarmntherapy, five milligrams per day for three days. The daily dose was decreased to 2.5 milligrams on September 2 1. On that day the patient's prothrombin time was three times the control value and heparmn therapy was discontinued. On September 22, ecchymosis of the right great, second, and third toes developed. During the next twenty-four hours, the ecchymosis spread to all of the toes and to the mid-metatarsal level of the dorsal and plantar surfaces of the foot. The following day a similar spreading lesion de veloped in the first three toes of the left foot. There was pain in both feet which gradually became severe. On the third day after the onset of the lesions, the toes became cold and purple, with erythema and swelling of the entire right foot to the level of the ankle joint. The dorsalis pedis and posterior tibial pulses remained strong and palpable in both feet. There was decreased sensitivity to light touch and pinprick in the involved toes, but deep pain and proprioception were intact. By September 25, large hemorrhagic bullae had developed over the toes of both feet extending onto the dorsum of the right foot. Roentgen ograms on this date did not demonstrate signs of subcutaneous em physema or bone changes . Because of the diagnosis of coumarin ne crosis , the coumarmn therapy was discontinued on September 28 . Heparmn therapy was reinstituted , resulting in gradual resolution of the erythema and ecchymosis. Doppler ultrasound tests showed that the pulsations of
The right foot of our patient, two months after the onset of coumarin necrosis. Well demarcated necrosis of the skin and soft tissues is present. the dorsalis pedis, posterior tibial, and digital arteries of the great toe were normal in both feet. There was frank necrosis of the skin of the toes with demarcation at their bases. The pain in the feet had decreased and the patient was able to walk comfortably. The patient was treated with cyclophosphamide and local irradiation for the lung carcinoma. 
Discussion
Twenty-five cases of this entity have been reported in the English literature to date, and in 1968 a review of the world literature showed 150 reported 4. The lesion is usually seen three to ten days after be ginning therapy with coumarin derivatives . Ninety-three per cent of the cases were manifest three to five days fol lowing the institution of coumarin therapy. Ninety per cent of the patients reported with this lesion were women. The average age of the patients was approximately fifty years, with a range of eighteen to ninety-three years . The lower half of the body was affected 80 per cent of the time and approximately one-fourth of the patients had lesions at multiple sites . Twenty per cent of the cases were bilateral and moderately symmetrical . Only one other case in the English literature, reported by Bahadir et al. in 1977, re suited in amputation.
The most widely held theory of pathogenesis is that a chemical toxicity directly affects the endothelial cells, mi tially at the dermovascular loop at the junction of the pre capillary arteriole and the capillary2 . A resulting vasodila tion produces erythematous flushing , with subsequent rup ture of the capillary walls producing a petechiai rash. The anticoagulant then acts systemically so that the bleeding is protracted and the ecchymosis and bullae develop. Infarc tion and necrosis follow due to thrombosis of the venules, secondary to the stasis distal to the capillary loop2.
Other causal mechanisms have been ed2 , chief among which are hypoprothrombinemia and a hypersen sitivity reaction. Hypoprothrombinemia is unlikely be cause no generalized hemorrhagic lesions are present, and the prothrombin time is typically in the therapeutic range.
The postulated hypersensitivity is supported by sev eral findings6. The lesions seem to occur more commonly after the second course of coumarmn therapy rather than after the first. Also, there is a histological as well as a din ical resemblance between these lesions and the lesions of the Schwartzmann phenomenon. Some findings do not support the hypersensitivity explanation2 . Subcutaneous in jections of coumarmn derivatives in affected patients have revealed negative results and there have not been any con sistent findings of an allergic vasculitis.
The currently accepted treatment of the lesions is immediate discontinuation of the coumarmn therapy and the initiation of intravenous administration of heparmn in high doses5 . This treatment may or may not be effective in stopping the progression of the lesion, depending on the stage at which the lesion is diagnosed. Unless the treat ment is begun early, the lesions will follow their natural course, as was evident in our patient. With progression to gangrene, escharectomy and skin-grafting should be con sidered rather than amputation, as the necrosis usually is superficial and the deeper tissues remain viable.
